Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Acta Medica Philippina ; : 0-2.
Article in English | WPRIM | ID: wpr-959548

ABSTRACT

One hundred thirty-four lung cancer cases who were histologically proven in life and who had chest x-rays at time of initial diagnosis were entered into this retrospective study covering the period from January 1, 1979 to April 30, 1985The major histologic subtype of lung cancer in this study were similar to those cited by foreign literatures, namely epidermoid cell cancer (37). Adenocarcinoma (25), small cell cancer (20) and large cell cancer (5). By frequency and odds ratio, squamous cell and adenocarcinoma histologies presented with a peripheral radiographic location two times more than with a central location. On the other hand, small cell cancer histology was three times more associated with central radiogaphic presentation. Large cell cancer histology showed to be either centrally or peripherally located without preference. (author)

2.
Southeast Asian J Trop Med Public Health ; 1985 Dec; 16(4): 660-4
Article in English | IMSEAR | ID: sea-31231

ABSTRACT

Twenty-two patients with advanced or recurrent cancer of the cervix treated with cis-platinum, adriamycin and cyclophosphamide were evaluated. Nine of 22 (41% achieved objective response (2 CR + 7PR), 9/22 (41%) stable disease, 4/22 (18%) progressive disease. The mean duration of response was 24.6 weeks, with a range of 18-28 weeks. Patients with poorly differentiated histologic grade and without previous treatment had better response rates. Responders had longer survival (mean 63.5 + weeks) than nonresponders (mean 30.5 weeks). Commonly encountered toxicities were alopecia, nausea and vomiting, and leucopenia, which were all tolerable.


Subject(s)
Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Carcinoma, Squamous Cell/drug therapy , Cisplatin/adverse effects , Cyclophosphamide/adverse effects , Doxorubicin/adverse effects , Female , Humans , Middle Aged , Neoplasm Recurrence, Local/drug therapy , Uterine Cervical Neoplasms/drug therapy
3.
Southeast Asian J Trop Med Public Health ; 1985 Dec; 16(4): 634-7
Article in English | IMSEAR | ID: sea-34375

ABSTRACT

The efficacy and tolerability of the combined scheme of administering high dose medroxyprogesterone acetate in advanced breast cancer is evaluated.


Subject(s)
Administration, Oral , Aged , Antineoplastic Agents/administration & dosage , Breast Neoplasms/drug therapy , Female , Humans , Injections, Intramuscular , Medroxyprogesterone/administration & dosage , Medroxyprogesterone Acetate , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL